What is the optimal mode of delivery for the haemophilia carrier expecting an affected infant-vaginal delivery or caesarean delivery?
Madan
B
B
The Centre for Haemostasis and Thrombosis, St Thomas' Hospital, London, UK.
Street
A M
AM
D001779:Blood Coagulation Factors / Q000627:therapeutic use; D036861:Delivery, Obstetric / Q000379:methods*; D019468:Disease Management; D005260:Female; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy; D006470:Hemorrhage / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D020300:Intracranial Hemorrhages / Q000453:epidemiology / Q000209:etiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control; D012306:Risk
D001779:Blood Coagulation Factors